ONENESS BIOTECH CO., LTD. Environmental Analytics
Environmental and financial analysis dashboard for ONENESS BIOTECH CO., LTD.. Industry: MANUFACTURING
Company Overview for ONENESS BIOTECH CO., LTD.
Highlights
Showing data for FY2022
Operational Environmental Cost
$0.43m
Operational Environmental Cost Intensity
1.24%
Total Environmental Cost
$0.44m
Total Environmental Cost Intensity
1.28%
ΔOperational Environmental Cost (2020-2022)
$0.17m
Decoupling Rate (2020-2022)
73%
Adjusted EBITDA
$31m
Adjusted EBITDA Margin
88%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 73.75% | 154.41% | N/A | ||
| 0.99% | 1.07% | 0.19% | N/A | |
| 32.26% | 13.84% | N/A | ||
| 16.43% | 13.51% | 1.06% | N/A | |
| $0m | $0m | $0m | N/A | |
| 34.61% | 24.14% | N/A | ||
| 17.42% | 14.58% | 1.24% | N/A | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | -89.20% | N/A | ||
| N/A | 4.65% | 0.03% | N/A | |
| N/A | -3.27% | N/A | ||
| N/A | 19.23% | 1.28% | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
88%
Adjusted EBIT Margin
42%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$1m | $2m | $35m | $3m | |
| 60.81% | 1356.72% | -91.84% | ||
$3m | $9m | $4m | N/A | |
| 225.34% | 394.56% | 10.76% | 0.00% | |
$-2m | $-7m | $31m | N/A | |
| -125.34% | -294.56% | 89.24% | 0.00% | |
$-9m | $-14m | $15m | N/A | |
| -588.30% | -594.64% | 42.82% | 0.00% | |
| ENVIRONMENTAL COST DATA | ||||
$0m | $0m | $0m | N/A | |
| 17.42% | 14.58% | 1.24% | 0.00% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$-2m | $-7m | $31m | N/A | |
| -142.76% | -309.15% | 87.99% | 0.00% | |
$-9m | $-14m | $14m | N/A | |
| -605.72% | -609.22% | 41.57% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.19%
Scope 2 (% of Sales)
1.06%
Operational Environmental Cost Intensity
1.24%
Scope 3 (% of Sales)
0.03%
Total Environmental Cost Intensity
1.28%
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
ONENESS BIOTECH CO., LTD. | TW | $0m | 1.24% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $1m | 47.15% | N/A | N/A |
Energy-related activities (3) | $0m | 8.73% | N/A | N/A |
Upstream transportation (4) | $0m | 15.13% | N/A | N/A |
Waste (5) | $0m | 1.04% | N/A | N/A |
Business travel (6) | $0m | 0.65% | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $0m | 9.35% | N/A | N/A |
Processing of products (10) | $0m | 0.02% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $0m | 17.92% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $2m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022